Back
Eaton Vance Risk-Managed Diversified Equity Income Fund Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Sell
43
ETJ
Eaton Vance Risk-Managed Diversified Equity Income Fund
Last Price:
$8.73
Seasonality Move:
-0.15%
Buy
60
ZBIO
Zenas BioPharma, Inc.
Last Price:
$41.85
Seasonality Move:
0.59%
Sell
43
Eaton Vance Risk-Managed Diversified Equity Income Fund (ETJ)
is a Sell
Is Eaton Vance Risk-Managed Diversified Equity Income Fund a Buy, Sell or Hold?
-
The current Eaton Vance Risk-Managed Diversified Equity Income Fund [ETJ] share price is $8.77. The Score for ETJ is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ETJ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Zenas BioPharma, Inc. (ZBIO)
is a Buy
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $42.33. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ETJ Stock Price Chart
What is Eaton Vance Risk-Managed Diversified Equity Income Fund's stock price today?
-
The Eaton Vance Risk-Managed Diversified Equity Income Fund share price today is $8.77The current trend is relatively stagnant and ETJ is experiencing slight buying pressure.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $42.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ETJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 50.91 | Buy |
| Chaikin Money Flow: | 50345 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.63 - 8.83) | Buy |
| Bollinger Bands (100): | (8.77 - 9.01) | Sell |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.47 | Buy |
| Relative Strength Index (14 RSI): | 61.08 | Buy |
| Chaikin Money Flow: | 587345 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.32 - 39.82) | Buy |
| Bollinger Bands (100): | (17.72 - 34.64) | Buy |
ETJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.7 | Buy |
| 20-day SMA: | 8.76 | Buy |
| 50-day SMA: | 8.81 | Sell |
| 200-day SMA: | 8.79 | Sell |
| 8-day EMA: | 8.72 | Buy |
| 20-day EMA: | 8.74 | Buy |
| 50-day EMA: | 8.8 | Sell |
| 200-day EMA: | 8.85 | Sell |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.46 | Buy |
| 20-day SMA: | 37.97 | Buy |
| 50-day SMA: | 33.51 | Buy |
| 200-day SMA: | 18.21 | Buy |
| 8-day EMA: | 24.11 | Buy |
| 20-day EMA: | 12.41 | Buy |
| 50-day EMA: | 5.54 | Buy |
| 200-day EMA: | 1.47 | Buy |
Eaton Vance Risk-Managed Diversified Equity Income Fund Earnings Growth & ETJ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
Eaton Vance Risk-Managed Diversified Equity Income Fund Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||